Navigation Links
AquaBounty Cleared To Produce Salmon Eggs In Canada For Commercial Purposes
Date:11/25/2013

MAYNARD, Mass., Nov. 25, 2013 /PRNewswire/ -- AquaBounty Technologies, Inc. (AIM: ABTX), a biotechnology company focused on enhancing productivity in the aquaculture market and a majority owned subsidiary of Intrexon Corporation (NYSE: XON), announces that Environment Canada, the agency of the Government of Canada with responsibility for regulating environmental policies and issues, has decided that AquAdvantage® Salmon ("AAS") is not harmful to the environment or human health when produced in contained facilities.  The publication of the Significant New Activity Notice (http://gazette.gc.ca/rp-pr/p1/2013/2013-11-23/html/notice-avis-eng.html#d106) recognizes that our hatchery, which produces sterile, all-female eggs, is no longer solely a research facility but can produce eggs on a commercial scale without harm to the environment or human health.

"We are pleased to note that, after a rigorous examination of our hatchery facility and the Standard Operating Procedures used to produce AAS eggs, Environment Canada is satisfied that we can responsibly produce our sterile, all-female eggs on a commercial scale," said Ron Stotish, AquaBounty CEO. "This is a significant milestone in our efforts to make AquAdvantage® Salmon available for commercial production. However, our eggs and fish will not be available for sale until they are approved by the relevant national regulatory bodies. When these approvals are in place, we look forward to demonstrating the value of AAS for a land-based and environmentally-sustainable production system."

Environment Canada made its conclusion following a risk assessment conducted by Fisheries and Oceans Canada involving a panel of independent scientific experts knowledgeable in the fields of transgenics and fish containment technology.

The publication describes conditions that would be regarded as Significant New Activities (SNAcs) with regard to AquAdvantage® Salmon and the measures Environment Canada would expect to evaluate if those activities were proposed. AquaBounty confirms that, currently, all anticipated activities fall well within the scope of the approval given by Environment Canada.

About AquaBounty Technologies

AquaBounty Technologies is a biotechnology company focused on improving productivity in commercial aquaculture, a $100 billion industry and the fastest growing segment of the worldwide food industry. The company's objective is the application of biotechnology to ensure the availability of high quality seafood to meet global consumer demand. The company is developing products to address critical production constraints in the most popular farmed species, focusing initially on salmon, trout and tilapia.  Its AquAdvantage® fish program is based upon a single, specific molecular modification in fish that results in more rapid growth in early development.

Safe Harbor Statement

Some of the statements made in this press release are forward-looking statements.  These forward-looking statements are based upon our current expectations and projections about future events and generally relate to our plans, objectives and expectations for the development of our business.  Although management believes that the plans and objectives reflected in or suggested by these forward-looking statements are reasonable, all forward-looking statements involve risks and uncertainties and actual future results may be materially different from the plans, objectives and expectations expressed in this press release.


'/>"/>
SOURCE Aqua Bounty Technologies
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. BioMedical Life Systems, Inc. Launches New FDA Cleared Non-Prescription TENS Device
2. New techniques produce cleanest graphene yet
3. New Hudsonville-Based Biomedical Startup, Imago Prints, Uses Patient-Specific Ultrasound Data to Produce One-of-a-Kind 3D Printed Renderings of Infants During Pregnancy
4. Researchers produce nanostructures with potential to advance energy devices
5. BIT Group Partners with BioNano Genomics to Produce Revolutionary Genomics Platform
6. New Method to Produce Blood Cells from Stem Cells Could Yield a Purer, Safer Cell Therapy
7. New Way to Mass-produce Natural Cancer-killing Cells Offers Hope for Patients
8. Stem cells produce compact, regenerated bone in mandible transplants
9. Genomatica and DuPont Tate & Lyle Bio Products Successfully Produce 1,4-Butanediol (BDO) on Commercial Scale
10. Boston College researchers unique nanostructure produces novel plasmonic halos
11. SurePure Seals Deal with Major Mexican Food Producer Signifying Continued Traction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 2016 , ... Newly created 4Sight Medical Solutions ... healthcare market. The company's primary focus is on new product introductions, to include ... are necessary to help companies efficiently bring their products to market. , The ...
(Date:6/24/2016)...  Regular discussions on a range of subjects including policies, ... entities said Poloz. Speaking at a lecture to ... he pointed to the country,s inflation target, which is set ... "In certain areas there needs ... economic goals, why not sit down and address strategy together?" ...
(Date:6/23/2016)... WA (PRWEB) , ... June 23, 2016 , ... ... announces the release of its second eBook, “Clinical Trials Patient Recruitment and Retention ... recruitment and retention in this eBook by providing practical tips, tools, and strategies ...
(Date:6/23/2016)... -- A person commits a crime, and the detective uses ... criminal down. An outbreak of foodborne illness makes ... uses DNA evidence to track down the bacteria that caused ... not. The FDA has increasingly used a complex, cutting-edge technology ... Put as simply as possible, whole genome sequencing is a ...
Breaking Biology Technology:
(Date:6/2/2016)... , June 2, 2016 ... Manned Platforms, Unmanned Systems, Physical Infrastructure, Support & Other ... provider visiongain offers comprehensive analysis of the ... this market will generate revenues of $17.98 billion in ... acquired DVTEL Inc, a leader in software and hardware ...
(Date:5/24/2016)... Calif. , May 24, 2016 Ampronix facilitates superior patient care by ... LMD3251MT  3D medical LCD display is the latest premium product recently added to the ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
Breaking Biology News(10 mins):